Hypertension Trial, Recruiting (NCT05662696)

Hypertension Trial, Recruiting NCT05662696 Sponsor: University Health Network, Toronto Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT05662696 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Pregnant women who are in their first or second trimester and are considered at high risk for a condition called preeclampsia (a serious blood pressure condition during pregnancy). High risk is defined using NICE guidelines, meaning the person has either one major risk factor or more than one moderate risk factor for preeclampsia.
People who can speak and read Urdu, at least at a basic level (with help from a caregiver if needed), so they can communicate with the research team and use the remote monitoring system.
Partners and/or other caregivers of the pregnant women — such as husbands, mothers, or mothers-in-law — may be eligible to take part in interviews after the study.
Doctors and nurses involved in running the remote monitoring program may also be eligible to take part in post-study interviews.

Who may not be able to join:

Pregnant women who are already admitted to hospital for treatment of preeclampsia would not be eligible to take part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emily Seto, PhD, University of Toronto

Phone: 416-669-9295

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05662696

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 416-669-9295

More information: https://clinicaltrials.gov/study/NCT05662696

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Pregnant women who are in their first or second trimester and are considered at high risk for a condition called preeclampsia (a serious blood pressure condition during pregnancy). High risk is defined using NICE guidelines, meaning the person has either one major risk factor or more than one moderate risk factor for preeclampsia.
People who can speak and read Urdu, at least at a basic level (with help from a caregiver if needed), so they can communicate with the research team and use the remote monitoring system.
Partners and/or other caregivers of the pregnant women — such as husbands, mothers, or mothers-in-law — may be eligible to take part in interviews after the study.
Doctors and nurses involved in running the remote monitoring program may also be eligible to take part in post-study interviews.

Who may not be able to join:

Pregnant women who are already admitted to hospital for treatment of preeclampsia would not be eligible to take part.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

4 August 2024

Est. completion

1 March 2027

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Acceptability; Demand; Practicality; Fidelity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov